Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

Mobb Deep may not be fully with us anymore, with Prodigy passing away in 2017 due to sickle cell anemia, but their legacy lives on. The Alchemist recently confirmed that he is working on the duo’s ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

The first Black graduate of The University of Texas at Austin, Oscar Thompson, studied zoology, as did trailblazing Longhorn ...

Kyle Registre's childhood dream of becoming a pilot can finally come true now that he says he's been cured of sickle cell ...

SSM Health Cardinal Glennon Children's Hospital partners with Eye See Me African Bookstore to provide books promoting ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...

Folks danced and grooved for 24 hours straight in honor St. John Fisher University’s annual Teddi Dance for Love, a ...

In an exclusive interview, one of UCLA's top scientists spoke out about what the disruptions in funding could mean to you and to science.